The cell cycle analysis market is expected to show a prominent growth during the forecast period (2018–2023).
Cell cycle analysis products are used in numerous life science research activities as well as in biomedical research and clinical research laboratories. Cell cycle analysis is carried out to check the effects of various internal and external factors on cells. Increasing expenditure on cell level research by the corporate sector, government initiatives for cell research, increasing chronic genetic diseases, rising occurrence of cell-specific diseases, and cancer and aggressive strategies by market players are expected to drive the growth of the market. For instance, In March 2018, Agilent technologies which is one of the major players in the cell cycle analysis market acquired advanced analytical technologies for USD 250 million.
The high costs of cell analysis instruments and expensive maintenance might be a problem for small research groups and it can hamper the growth of the market during the assessment period.
Cell Cycle Analysis Market Segmentation
The cell cycle analysis market has been segmented on the basis of product, application, and end-user.
On the basis of product, the market has been classified as consumables and instruments. The consumables segment has been further divided into reagents, assay kits, microplates, and other consumables. The assay kits segment has been further divided into immunoassay and cell-based assay. The instruments segment has been classified into microscopes, flow cytometry, spectrophotometer, qPCR, cell counter, high content screening systems, and cell microarrays. The microscopes segment has been divided into electron microscopes, inverted microscopes, stereomicroscopes, fluorescence and confocal microscopes, phase contrast microscopes, Near-Field Scanning Optical Microscopes (NSOM), and other microscopes. The flow cytometers sub-segment has been segmented into flow cytometry instruments and flow cytometry software. The spectrophotometers segment has been divided into fluorescence microplate readers, microplate spectrophotometers, and colorimeters. Furthermore, cell counters have been sub-segmented into automated cell counters and hemocytometers and manual cell counters. The synthetic High-Content Screening (HCS) systems segment includes cell imaging and analysis HCS systems and HCS software.
The market, by application, has been segmented into cell identification, cell viability, cell signaling pathway/signal transduction, cell proliferation, cell counting and quality control, cell interaction, cell structure study, target identification, and validation and single-cell analysis.
Based on end-user, the market has been divided into, academics and research institutions, hospitals and diagnostic laboratories, pharmaceuticals (CROs and biotechnology companies), and other end-users.
Company Profiles
Cell Cycle Analysis Market, by Product
Cell Cycle Analysis Market, by Application
Cell Cycle Analysis Market, by End-User
Cell Cycle Analysis Market, by Region